Vol 4 (July 30, 2021): Annals of Pancreatic Cancer

Review Article
 
Solid pseudopapillary neoplasm of the pancreas: cytomorphology, pitfalls, and literature review
Payam S. Pahlavan, Amer Khiyami, Santhi Ganesan
Annals of Pancreatic Cancer  
2021;
4:
5  
Review Article
 
Volatile organic compound analysis for the diagnosis of pancreatic cancer
Benjamin T. Crosby, Adam Ridzuan-Allen, John P. O’Neill
Annals of Pancreatic Cancer  
2021;
4:
4  
Original Article 
A national database analysis of acinar cell carcinoma of the pancreas, a histologically, epidemiologically, and biologically distinct entity increasing in incidence
Jennifer A. Yonkus, John R. Bergquist, Roberto Alva-Ruiz, Tommy Ivanics, Elizabeth B. Habermann, Amro M. Abdelrahman, Travis E. Grotz, Sean P. Cleary, Rory L. Smoot, David M. Nagorney, Michael L. Kendrick, Thorvardur R. Halfdanarson, Mark J. Truty
Annals of Pancreatic Cancer  
2021;
4:
3  
Original Article 
A Phase 1b clinical trial of LDE225 (Sonidegib) in combination with fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFIRINOX) in previously untreated locally advanced or metastatic pancreatic adenocarcinoma
Jeffrey W. Clark, Nora Horick, Jill N. Allen, Lawrence S. Blaszkowsky, Janet E. Murphy, Charles S. Fuchs, Brian M. Wolpin, Robert J. Mayer, Jason E. Farris, Jennifer A. Chan, Kimmie Ng, Nadine J. McCleary, Thomas A. Abrams, David P. Ryan, Eunice L. Kwak, Theodore S. Hong
Annals of Pancreatic Cancer  
2021;
4:
2  
Original Article 
Association of germline ATM mutations and survival in pancreatic cancer
Arjan Gower, Gillian Gresham, Kellie Spector, Nanor Haladjian, John Lee, Sejal Mehta, Arsen Osipov, Andrew Hendifar
Annals of Pancreatic Cancer  
2021;
4:
1